{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:03:19Z","timestamp":1793228599486,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI16C2300"],"award-info":[{"award-number":["HI16C2300"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Mycoplasma pneumoniae<\/jats:italic> is one of the most common pathogens causing community acquired pneumonia in children. Although the rate of macrolide-refractory <jats:italic>Mycoplasma pneumoniae<\/jats:italic> (MRMP) has increased, systemic glucocorticoids as a treatment option has not been validated yet. The purpose of this study was to assess the efficacy of glucocorticoids add-on in the treatment of MRMP in children through systematic review and meta-analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p><jats:bold>Data sources<\/jats:bold><\/jats:p>\n                <jats:p>A systematic literature search was conducted using ten electronic bibliographic databases including English, Korean, Chinese and Japanese languages, up to March 8, 2018.<\/jats:p>\n                <jats:p><jats:bold>Study selection<\/jats:bold><\/jats:p>\n                <jats:p>The study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist and selected randomized control trials which compared the efficacy of glucocorticoids add-on to macrolide in the treatment of MRMP in children.<\/jats:p>\n                <jats:p><jats:bold>Data extraction<\/jats:bold><\/jats:p>\n                <jats:p>Two independent reviewers extracted: primary outcomes as hospital days, fever duration, and change in C-reactive protein (CRP) and main analysis was performed through meta-analysis with random effects model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-four unique randomized controlled trials met the inclusion criteria. The mean length of hospital stay in glucocorticoids treatment group was significantly shorter than that in conventional macrolide-treatment group (Weighted mean difference (WMD)\u2009=\u2009\u2212\u20094.03\u2009days). The mean length of fever duration was significantly shorter in the glucocorticoid treatment group in comparison with the conventional treatment group (WMD\u2009=\u2009-3.32\u2009days). Level of CRP after treatment was significantly lower in the glucocorticoid treatment group than that in the conventional treatment group (WMD\u2009=\u2009-16.03). Sensitivity analysis and subgroup analysis showed no significant improvement in heterogeneity. As limitations of the study, most of the studies included were from a single country and we were unable to control for heterogeneity across interventions, lack of standardized measures, and different time points of assessments across studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Glucocorticoid add-on treatment for MRMP can significantly shorten the duration of fever and hospital stay and decrease the level of CRP. These results should be confirmed by adequately powered studies in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-019-0990-8","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T18:02:48Z","timestamp":1576692168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"19","author":[{"given":"Hwan Soo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Suk","family":"Sol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Suk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hee","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7287-4300","authenticated-orcid":false,"given":"Hyeon-Jong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"key":"990_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3345\/kjp.2017.60.5.151","volume":"60","author":"E Lee","year":"2017","unstructured":"Lee E, Cho HJ, Hong SJ, Lee J, Sung H, Yu J. Prevalence and clinical manifestations of macrolide resistant mycoplasma pneumoniae pneumonia in Korean children. Korean J Pediatr. 2017;60:151\u20137.","journal-title":"Korean J Pediatr"},{"key":"990_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fmicb.2016.00329","volume":"7","author":"PM Meyer Sauteur","year":"2016","unstructured":"Meyer Sauteur PM, Unger WW, Nadal D, Berger C, Vink C, van Rossum AM. Infection with and carriage of mycoplasma pneumoniae in children. Front Microbiol. 2016;7:329.","journal-title":"Front Microbiol"},{"key":"990_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fmicb.2016.00693","volume":"7","author":"T Yamazaki","year":"2016","unstructured":"Yamazaki T, Kenri T. Epidemiology of mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M pneumoniae. Front Microbiol. 2016;7:693.","journal-title":"Front Microbiol"},{"key":"990_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3345\/kjp.2017.60.6.167","volume":"60","author":"HJ Yang","year":"2017","unstructured":"Yang HJ, Song DJ, Shim JY. Mechanism of resistance acquisition and treatment of macrolide-resistant mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2017;60:167\u201374.","journal-title":"Korean J Pediatr"},{"key":"990_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3345\/kjp.2012.55.2.42","volume":"55","author":"YS Youn","year":"2012","unstructured":"Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2012;55:42\u20137.","journal-title":"Korean J Pediatr"},{"key":"990_CR6","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","volume":"377","author":"SC Meijvis","year":"2011","unstructured":"Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, van Velzen-Blad H, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377:2023\u201330.","journal-title":"Lancet"},{"key":"990_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4168\/aair.2014.6.1.22","volume":"6","author":"SY You","year":"2014","unstructured":"You SY, Jwa HJ, Yang EA, Kil HR, Lee JH. Effects of methylprednisolone pulse therapy on refractory mycoplasma pneumoniae pneumonia in children. Allergy Asthma Immunol Res. 2014;6:22\u20136.","journal-title":"Allergy Asthma Immunol Res"},{"key":"990_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.resinv.2017.11.005","volume":"56","author":"Y Okubo","year":"2018","unstructured":"Okubo Y, Michihata N, Morisaki N, Uda K, Miyairi I, Ogawa Y, et al. Recent trends in practice patterns and impact of corticosteroid use on pediatric mycoplasma pneumoniae-related respiratory infections. Respir Investig. 2018;56:158\u201365.","journal-title":"Respir Investig"},{"key":"990_CR9","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"990_CR10","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"990_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"990_CR12","first-page":"186","volume":"14","author":"X-L Shao","year":"2011","unstructured":"Shao X-L, Liu S-M, Lou W-Y, Zhu G-Z. Methylprednisolone in adjunctive treatment of refractory mycoplasma pneumonia. Chin Gen Pract. 2011;14:186\u20137.","journal-title":"Chin Gen Pract"},{"key":"990_CR13","first-page":"74","volume":"23","author":"T Xu-yun","year":"2015","unstructured":"Xu-yun T, Hong-yu Q. Clinical effect and safety of small-dose methylprednisolone triple therapy on refractory lobar mycoplasma pneumoniae pneumonia in children. Pract J Card Cerebral Pneumal Vasc Dis. 2015;23:74\u20136.","journal-title":"Pract J Card Cerebral Pneumal Vasc Dis"},{"key":"990_CR14","first-page":"18","volume":"21","author":"L Ling","year":"2015","unstructured":"Ling L. The effect of low-dose methylprednisolone in the treatment of children with refractory mycoplasma pneumoniae pneumonia. J Pediatr Pharm. 2015;21:18\u201321.","journal-title":"J Pediatr Pharm"},{"key":"990_CR15","first-page":"10","volume":"12","author":"L Ming","year":"2015","unstructured":"Ming L, Ye-qing H. Small doses of methyl prednisolone sodium succinate and prednisone combined treatment the curative effect of children refractory mycoplasma pneumoniae pneumonia. Medical Innovation of China. 2015;12:10\u20133.","journal-title":"Medical Innovation of China"},{"key":"990_CR16","first-page":"148","volume":"7","author":"L Jianqin","year":"2015","unstructured":"Jianqin L. Evaluation clinical curative effect of methylprednisolone in treatment of 42 case children with refractory mycoplasma pneumonia. China Contin Med Educ. 2015;7:148\u20139.","journal-title":"China Contin Med Educ"},{"key":"990_CR17","first-page":"82","volume":"22","author":"L Yan","year":"2015","unstructured":"Yan L, Wei L. Effect of low-dose glucocorticoid in the treatment of children with refractory mycoplasma pneumonia. China Mod Med. 2015;22:82\u20134.","journal-title":"China Mod Med"},{"key":"990_CR18","first-page":"246","volume":"36","author":"F Xuwei","year":"2015","unstructured":"Xuwei F. Methylprednisolone combined with azithromycin in treatment of children with refractory mycoplasma pneumonia (RMPP) efficacy and safety. Prog Biomed Eng. 2015;36:246\u20138.","journal-title":"Prog Biomed Eng"},{"key":"990_CR19","first-page":"142","volume":"7","author":"Y Lijun","year":"2015","unstructured":"Lijun Y. Clinical curative effect analysis of methyl prednisolone auxiliary treatment of refractory mycoplasma pneumonia. China Contin Med Educ. 2015;7:142\u20133.","journal-title":"China Contin Med Educ"},{"key":"990_CR20","first-page":"588","volume":"18","author":"R Ming-xing","year":"2015","unstructured":"Ming-xing R, Guochang X, Linna S, Huan X, Yuejuan S, Li C. Efficacy and safety of methylprednisolone combined with azithromycin on refractory mycoplasma pneumonia in children. Chin Gen Pract. 2015;18:588\u201391.","journal-title":"Chin Gen Pract"},{"key":"990_CR21","first-page":"1472","volume":"20","author":"X Zhang","year":"2015","unstructured":"Zhang X. Clinical study of glucocorticoid in the treatment of refractory mycoplasma pneumoniae pneumonia. J Clin Pulm Med. 2015;20:1472\u20135.","journal-title":"J Clin Pulm Med"},{"key":"990_CR22","first-page":"25","volume":"22","author":"L Qing","year":"2016","unstructured":"Qing L, Hu L, Ling Z, Yajun H. Effect of therapy with glucocorticoids in children with refractory mycoplasma pneumoniae pneumonia. J Pediatr Pharm. 2016;22:25\u20137.","journal-title":"J Pediatr Pharm"},{"key":"990_CR23","first-page":"31","volume":"32","author":"W Jianjun","year":"2016","unstructured":"Jianjun W. Study on the effect of azithromycin and methylprednisolone in the treatment of children with refractory mycoplasma pneumonia. Chin Community Dr. 2016;32:31\u20133.","journal-title":"Chin Community Dr"},{"key":"990_CR24","first-page":"442","volume":"44","author":"W Hao","year":"2016","unstructured":"Hao W, Jingrong Y, Jinglin O. Clinical effect of methylprednisolone combined with azithromycin in the treatment of children with RMPP. Med Sci J Cent South China. 2016;44:442\u20136.","journal-title":"Med Sci J Cent South China"},{"key":"990_CR25","first-page":"1351","volume":"16","author":"Z Xuan","year":"2016","unstructured":"Xuan Z, Juanjuan Z, Huichao J, Yang Z. Observation on efficacy of methylprednisolone in treatment of children with refractory mycoplasma pneumoniae. Eval Anal Drug-Use Hosp China. 2016;16:1351\u20133.","journal-title":"Eval Anal Drug-Use Hosp China"},{"key":"990_CR26","first-page":"92","volume":"5","author":"F Xiaoqiang","year":"2016","unstructured":"Xiaoqiang F, Chunyan G, Xiaohong H, Shiping L. Clinical analysis of the effects of methylprednisolone on the treatment of refractory mycoplasma pneumoniae pneumonia in children. Transl Med J. 2016;5:92\u20135.","journal-title":"Transl Med J"},{"key":"990_CR27","first-page":"37","volume":"23","author":"Q Hai-yan","year":"2017","unstructured":"Hai-yan Q. To observe the curative effect of small dose of glucocorticoid combined with Pulmicort inhalation in the treatment of refractory mycoplasma pneumonia. Contemp Med. 2017;23:37\u20139.","journal-title":"Contemp Med"},{"key":"990_CR28","first-page":"22","volume":"46","author":"J Chaoyu","year":"2017","unstructured":"Chaoyu J, Rongfang M. Hormone refractory mycoplasma pneumonia lavage cytokines. Shaanxi Med J. 2017;46:22\u20134.","journal-title":"Shaanxi Med J"},{"key":"990_CR29","first-page":"14","volume":"23","author":"L Xiaoyun","year":"2017","unstructured":"Xiaoyun L, Jinping F, Qiaoziang X. Intravenous methylprednisolone combined with azithromycin in treatment of children with refractory mycoplasma pneumonia and influence on relevant laboratory parameters. J Pediatr Pharm. 2017;23:14\u20136.","journal-title":"J Pediatr Pharm"},{"key":"990_CR30","first-page":"70","volume":"2","author":"L Chun-yan","year":"2017","unstructured":"Chun-yan L, Ling-zhi C. Clinical effect of methylprednisolone pluse therapy in treatment of refractory mycoplasma pneumoniae in children. Syst Med. 2017;2:70\u201387.","journal-title":"Syst Med"},{"key":"990_CR31","first-page":"155","volume":"25","author":"X Jia-li","year":"2017","unstructured":"Jia-li X, Ying W, Peng C. Clinical effect of methylprednisolone combined with azithromycin sequential therapy in treating children with mycoplasma pneumonia and the impact on serum levels CRP and sTREM-1. Pract J Card Cereb Pneumal Vasc Dis. 2017;25:155\u20137.","journal-title":"Pract J Card Cereb Pneumal Vasc Dis"},{"key":"990_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13020-017-0128-y","volume":"12","author":"J Yu","year":"2017","unstructured":"Yu J, Wang X, Wu C. Clinical analysis of methylprednisolone in the treatment of children refractory mycoplasma pneumoniae pneumonia. China Pract Med. 2017;12:7\u20139.","journal-title":"China Pract Med"},{"key":"990_CR33","first-page":"133","volume":"15","author":"X Wu","year":"2017","unstructured":"Wu X. Analysis of the effect of combined use of methylprednisolone and azithromycin on refractory mycoplasma pneumonia in children. Contemp Med Symp. 2017;15:133\u20134.","journal-title":"Contemp Med Symp"},{"key":"990_CR34","first-page":"798","volume":"23","author":"Z Shuqing","year":"2017","unstructured":"Shuqing Z, Yanrong Z. Effect of small doses of methylprednisolone treatment of children with refractory mycoplasma. Med Recapitulate. 2017;23:798\u2013801.","journal-title":"Med Recapitulate"},{"key":"990_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12519-017-0014-9","volume":"13","author":"LS Shan","year":"2017","unstructured":"Shan LS, Liu X, Kang XY, Wang F, Han XH, Shang YX. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory mycoplasma pneumoniae pneumonia in children. World J Pediatr. 2017;13:321\u20137.","journal-title":"World J Pediatr"},{"key":"990_CR36","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.rmed.2008.06.022","volume":"102","author":"A Defilippi","year":"2008","unstructured":"Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, et al. Epidemiology and clinical features of mycoplasma pneumoniae infection in children. Respir Med. 2008;102:1762\u20138.","journal-title":"Respir Med"},{"issue":"Suppl 2","key":"990_CR37","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27\u201372.","journal-title":"Clin Infect Dis"},{"key":"990_CR38","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","volume":"385","author":"CA Blum","year":"2015","unstructured":"Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2015;385:1511\u20138.","journal-title":"Lancet"},{"key":"990_CR39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","volume":"17","author":"KB Waites","year":"2004","unstructured":"Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697\u2013728.","journal-title":"Clin Microbiol Rev"},{"key":"990_CR40","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1378\/chest.121.5.1493","volume":"121","author":"H Tanaka","year":"2002","unstructured":"Tanaka H, Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, et al. Role of interleukin-18 and T-helper type 1 cytokines in the development of mycoplasma pneumoniae pneumonia in adults. Chest. 2002;121:1493\u20137.","journal-title":"Chest"},{"key":"990_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2567.2011.03408.x","volume":"133","author":"T Shimizu","year":"2011","unstructured":"Shimizu T, Kida Y, Kuwano K. Cytoadherence-dependent induction of inflammatory responses by mycoplasma pneumoniae. Immunology. 2011;133:51\u201361.","journal-title":"Immunology"},{"key":"990_CR42","first-page":"894","volume":"103","author":"JY Wang","year":"2004","unstructured":"Wang JY, Lee CH, Cheng SL, Chang HT, Hsu YL, Wang HC, et al. Comparison of the clinical manifestations of severe acute respiratory syndrome and mycoplasma pneumoniae pneumonia. J Formos Med Assoc. 2004;103:894\u20139.","journal-title":"J Formos Med Assoc"},{"key":"990_CR43","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/jac\/dks457","volume":"68","author":"N Principi","year":"2013","unstructured":"Principi N, Esposito S. Macrolide-resistant mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother. 2013;68:506\u201311.","journal-title":"J Antimicrob Chemother"},{"key":"990_CR44","first-page":"223","volume":"57","author":"A Tamura","year":"2008","unstructured":"Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T. Methylprednisolone pulse therapy for refractory mycoplasma pneumoniae pneumonia in children. J Inf Secur. 2008;57:223\u20138.","journal-title":"J Inf Secur"},{"key":"990_CR45","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1086\/591915","volume":"198","author":"C Tagliabue","year":"2008","unstructured":"Tagliabue C, Salvatore CM, Techasaensiri C, Mejias A, Torres JP, Katz K, et al. The impact of steroids given with macrolide therapy on experimental mycoplasma pneumoniae respiratory infection. J Infect Dis. 2008;198:1180\u20138.","journal-title":"J Infect Dis"},{"key":"990_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ppul.22752","volume":"49","author":"Z Luo","year":"2014","unstructured":"Luo Z, Luo J, Liu E, Xu X, Liu Y, Zeng F, et al. Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2014;49:377\u201380.","journal-title":"Pediatr Pulmonol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0990-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0990-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0990-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:09:49Z","timestamp":1608163789000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0990-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["990"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0990-8","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"31 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}